Search

The Human Immunodeficiency Virus (HIV), a retrovirus that attacks the immune system results in a continuous immunodeficiency that predisposes the infected to opportunistic infections, came to the fore in 1981. In the absence of a potent antiretroviral treatment, immunodeficiency is often in due...

The emergence of drug resistance among Human Immunodeficiency Virus (HIV) patients poses a significant challenge to the success of antiretroviral therapy (ART) programs globally. In Malawi, where HIV prevalence remains a major public health concern, the incorporation of Dolutegravir (DTG) into...